Xilin Wu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Men Who Have Sex With Men

Extracorporeal Membrane Oxygenation

Top Venues

EMBO molecular medicine

Nature communications

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Mengmeng Ji, Jiaqian Hu, Doudou Zhang, Bilian Huang, Shijie Xu, Na Jiang, Yuxin Chen, Yujiong Wang, Xilin Wu, Zhiwei Wu
Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody. EMBO molecular medicine 16 (3) (2024)
Linjing Zhu, Bilian Huang, Xiangyao Wang, Fengfeng Ni, Mingjun Ao, Ruoke Wang, Bin Zheng, Chen Chen, Jing Xue, Lin Zhu, Chenbo Yang, Lingen Shi, Shengya Geng, Jiaqian Hu, Mengshi Yang, Doudou Zhang, Ping Yang, Miaomiao Li, Yuncheng Li, Qinxue Hu, Sheng Ye, Peng Zheng, Hongxia Wei, Zhiwei Wu, Linqi Zhang, Yaxin Wang, Yalan Liu, Xilin Wu
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration. Nature communications 15 (1) (2024)
Mengmeng Ji, Jiaqian Hu, Doudou Zhang, Bilian Huang, Shijie Xu, Na Jiang, Yuxin Chen, Yujiong Wang, Xilin Wu, Zhiwei Wu
Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody. EMBO molecular medicine (2024)
Mengmeng Ji, Jiaqian Hu, Doudou Zhang, Bilian Huang, Shijie Xu, Na Jiang, Yuxin Chen, Yujiong Wang, Xilin Wu, Zhiwei Wu
Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody. EMBO molecular medicine 16 (3) (2024)
Mengmeng Ji, Jiaqian Hu, Doudou Zhang, Bilian Huang, Shijie Xu, Na Jiang, Yuxin Chen, Yujiong Wang, Xilin Wu, Zhiwei Wu
Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody. EMBO molecular medicine 16 (3) (2024)
Mengmeng Ji, Jiaqian Hu, Doudou Zhang, Bilian Huang, Shijie Xu, Na Jiang, Yuxin Chen, Yujiong Wang, Xilin Wu, Zhiwei Wu
Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody. EMBO molecular medicine (2024)
Linjing Zhu, Bilian Huang, Xiangyao Wang, Fengfeng Ni, Mingjun Ao, Ruoke Wang, Bin Zheng, Chen Chen, Jing Xue, Lin Zhu, Chenbo Yang, Lingen Shi, Shengya Geng, Jiaqian Hu, Mengshi Yang, Doudou Zhang, Ping Yang, Miaomiao Li, Yuncheng Li, Qinxue Hu, Sheng Ye, Peng Zheng, Hongxia Wei, Zhiwei Wu, Linqi Zhang, Yaxin Wang, Yalan Liu, Xilin Wu
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration. Nature communications 15 (1) (2024)
Mengmeng Ji, Jiaqian Hu, Doudou Zhang, Bilian Huang, Shijie Xu, Na Jiang, Yuxin Chen, Yujiong Wang, Xilin Wu, Zhiwei Wu
Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody. EMBO molecular medicine 16 (3) (2024)
Linjing Zhu, Bilian Huang, Xiangyao Wang, Fengfeng Ni, Mingjun Ao, Ruoke Wang, Bin Zheng, Chen Chen, Jing Xue, Lin Zhu, Chenbo Yang, Lingen Shi, Shengya Geng, Jiaqian Hu, Mengshi Yang, Doudou Zhang, Ping Yang, Miaomiao Li, Yuncheng Li, Qinxue Hu, Sheng Ye, Peng Zheng, Hongxia Wei, Zhiwei Wu, Linqi Zhang, Yaxin Wang, Yalan Liu, Xilin Wu
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration. Nature communications 15 (1) (2024)
Waqas Nawaz, Bilian Huang, Shijie Xu, Yanlei Li, Linjing Zhu, Hu Yiqiao, Zhiwei Wu, Xilin Wu
AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia. Blood cancer journal 11 (6) (2021)
Shijie Xu, Na Jiang, Waqas Nawaz, Bingxin Liu, Fang Zhang, Ye Liu, Xilin Wu, Zhiwei Wu
Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome. PLoS pathogens 17 (5) (2021)